Balanced news tone
News Sentiment
CELZ sentiment intelligence
Creative Medical Technology Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
44 relevant articles
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-24.6% over one week, -58.0% over four weeks, trend inactive, and below fair value.
Creative Medical Technology (CELZ) plans big share boost and warrant approval
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
84/100 classification
One-week reaction
-24.6%
Price reacting lower
Trend fit
Trend inactive
-58.0% over four weeks
Fair value
-72.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
10
Neutral
26
Negative
8
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
Creative Medical Technology (CELZ) plans big share boost and warrant approval
Creative Medical Technology Holdings, Inc. (CELZ) is calling a special stockholder meeting on August 28, 2026, to vote on two key proposals. These include increasing authorized common stock from 25 million to 100 million shares and approving the full exercise of private-placement
- Tone
- Negative 39/100
- Event
- Regulatory and legal
- Published
- 14 Jul 2026 19:49
- Source
- Stock Titan
Market source
Industry context
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Medical Buyer
Direct company coverage
Creative Medical Technology enters into agreement with existing warrant holders
Creative Medical Technology Holdings, Inc. entered into inducement agreements with existing warrant holders, lowering the exercise price from $2.86 to $1.60 per share, which led to the exercise of warrants covering 2,790,340 common shares and raised approximately $4.5 million. Th
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 08:12
- Source
- Medical Buyer
TradingView
Direct company coverage
Creative Medical Technology Raises $4.5M From Warrant Exercises, Reprices and Issues New 5-Year Warrants
Creative Medical Technology (CELZ) has reportedly raised approximately $4.5 million in gross proceeds through warrant exercise inducement letters with existing warrant holders. The company reduced the exercise price from $2.86 to $1.60 per share, and in return, will issue new ind
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 03 Jul 2026 11:10
- Source
- TradingView
TradingView
Direct company coverage
Creative Medical Technology awards $100,000 bonus to CEO Timothy Warbington
Creative Medical Technology Holdings (CELZ) has awarded its CEO, Timothy Warbington, a bonus of $100,000. The bonus was approved by the board's Compensation Committee and became effective on July 1, 2026. The information was sourced from an SEC 8-K filing.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:39
- Source
- TradingView
Stock Titan
Direct company coverage
Creative Medical (CELZ) secures $4.5M and issues 5.58M inducement warrants
Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through an inducement offer, encouraging warrant holders to exercise 2,790,340 existing warrants at a reduced price of $1.60 per share. In exchange, the company issued 5,580,680 n
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:39
- Source
- Stock Titan
Medical Buyer
Direct company coverage
Creative Medical Technology Holdings announces EoW agreements
Creative Medical Technology Holdings, Inc. has entered into agreements with warrant holders for the immediate exercise of outstanding warrants, originally issued in October 2025, at a reduced exercise price of $1.60 per share, generating approximately $4.5 million in gross procee
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 15:39
- Source
- Medical Buyer
StocksToTrade
Direct company coverage
Creative Medical Technology Holdings Inc. (CELZ) Stock Price | Live Quotes & Charts | NASDAQ
This page provides live stock quotes and charts for Creative Medical Technology Holdings Inc. (CELZ) on NASDAQ. It shows the current stock price, recent change, and offers a chart for various timeframes. The article also notes the absence of current analyst ratings and earnings i
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 08:39
- Source
- StocksToTrade
Stock Titan
Direct company coverage
Creative Medical (CELZ) asks shareholders to OK 5.58M warrants, 100M cap increase
Creative Medical Technology Holdings, Inc. (CELZ) is seeking shareholder approval for two proposals at a Special Meeting: to increase authorized common stock from 25 million to 100 million shares and to approve the exercise of 5.58 million Investor Warrants at $1.60 per share. Th
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 01 Jul 2026 21:09
- Source
- Stock Titan
Stock Titan
Direct company coverage
Creative Medical says FDA-cleared pain trial is 85% enrolled
Creative Medical Technology Holdings (NASDAQ: CELZ) provided a mid-year update for 2026, highlighting significant progress in its regenerative medicine and AI-enabled biodefense programs. The company reported that its Olastrocel (CELZ-201) treatment for chronic lower back pain sh
- Tone
- Positive 77/100
- Event
- Market update
- Published
- 01 Jul 2026 13:09
- Source
- Stock Titan
The Manila Times
Direct company coverage
Creative Medical Technology Holdings Issues Mid-Year Update
Creative Medical Technology Holdings, Inc. provided a mid-year update highlighting significant clinical, regulatory, and strategic progress across its core programs, including Olastrocel for chronic lower back pain, Ultrasome for osteoarthritis, and the CELZ-Biodefense Platform.
- Tone
- Positive 93/100
- Event
- Regulatory and legal
- Published
- 01 Jul 2026 10:00
- Source
- The Manila Times
The Manila Times
Direct company coverage
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
Creative Medical Technology Holdings (Nasdaq: CELZ) announced agreements with certain warrant holders for the immediate exercise of existing warrants, generating approximately $4.5 million in gross proceeds. The company will issue new unregistered warrants upon the receipt of sha
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 01 Jul 2026 08:41
- Source
- The Manila Times
GuruFocus
Direct company coverage
Creative Medical (CELZ) Secures $4.5M from Immediate Warrant Exercises
Creative Medical Technology Holdings Inc (CELZ) has announced it will receive approximately $4.5 million in gross proceeds from immediate warrant exercises by existing warrant holders. The company will issue new unregistered warrants for an additional 5,580,680 shares. Despite th
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 18:41
- Source
- GuruFocus
Quiver Quantitative
Direct company coverage
Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds
Creative Medical Technology Holdings (CELZ) announced agreements for the immediate exercise of warrants, expecting to raise about $4.5 million in gross proceeds. This funding, from warrant holders exercising at a reduced price of $1.60 per share, will be used for working capital
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 18:41
- Source
- Quiver Quantitative
Stock Titan
Direct company coverage
Creative Medical locks in $4.5M from warrant holders
Creative Medical Technology Holdings (CELZ) has secured approximately $4.5 million in gross proceeds through agreements for the immediate exercise of existing warrants at a reduced price of $1.60 per share. In exchange, the company will issue new, unregistered warrants for up to
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 30 Jun 2026 17:41
- Source
- Stock Titan
Benzinga
Direct company coverage
12 Health Care Stocks Moving In Tuesday's Intraday Session
This article identifies 12 healthcare stocks that experienced significant price movements during Tuesday's intraday trading session. It lists several gainers including Creative Medical Technologies, Cuprina Holdings, Abivax, C4 Therapeutics, Bio Green Med Solution, and ProMIS Neu
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 30 Jun 2026 16:41
- Source
- Benzinga
Quiver Quantitative
Direct company coverage
Creative Medical Technology Holdings surges as traders appear to chase recent clinical and platform updates
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 14:48
- Source
- Quiver Quantitative
Stock Titan
Direct company coverage
[RW] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing
Creative Medical Technology Holdings, Inc. has filed a request to withdraw its registration statement on Form S-1, which was filed on June 25, 2026. The company no longer plans to proceed with the offering of its securities described in the registration statement. They also reque
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 12:41
- Source
- Stock Titan
StocksToTrade
Direct company coverage
CELZ Stock Jumps As FDA Clears Expanded Pain Trial
Creative Medical Technology Holdings Inc. (CELZ) stock surged by over 380% after the FDA cleared an expansion of its ADAPT Phase 2 trial for CELZ-201, a treatment for chronic lower back pain. The expansion includes an additional 15 patients on lower-dose opioids, with enrollment
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 30 Jun 2026 10:04
- Source
- StocksToTrade
dars.gov.et
Direct company coverage
Creative Medical Technology (CELZ) Plunges 32.5% as Selling Pressure Intensifies - AAII Bearish
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Jun 2026 01:34
- Source
- dars.gov.et
Benzinga
Direct company coverage
Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May - Creative Medical Tech (NASDAQ:CELZ), Sad
U.S. stocks, especially the Nasdaq, experienced a significant dip on Friday, with the goods trade deficit widening to $105.8 billion in May, exceeding expectations. Healthcare shares saw gains while information technology stocks declined. Several individual stocks, including Sado
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 27 Jun 2026 08:40
- Source
- Benzinga
Stock Titan
Direct company coverage
[S-1/A] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Amends IPO Registration Statement
Creative Medical Technology Holdings, Inc. has amended its S-1 IPO registration statement, seeking to register 3,045,685 shares of common stock, 6,091,371 Public Warrants, and 3,045,685 pre-funded warrants. The offering, aiming for estimated net proceeds of $5.34 million, will fu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:41
- Source
- Stock Titan
Investing.com Australia
Direct company coverage
Form S-1/A Creative Medical Technology Holdings Inc For: 26 June By Investing.com
Investing.com reported on the Form S-1/A filing by Creative Medical Technology Holdings Inc for June 26. The article also included a standard disclaimer about the high risks involved in trading financial instruments and cryptocurrencies, emphasizing that data on their website may
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:41
- Source
- Investing.com Australia
TradingView
Direct company coverage
Creative Medical Technology Holdings, Inc. Actuals & Estimates (NASDAQ:CELZ)
This article provides a financial overview and analyst estimates for Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ). It covers the company's current stock price, recent performance, future forecasts, historical highs and lows, volatility, market capitalization, and upco
- Tone
- Negative 26/100
- Event
- Analyst action
- Published
- 26 Jun 2026 20:41
- Source
- TradingView
TradingView
Direct company coverage
Creative Medical Technology Holdings, Inc. Actuals & Estimates (BOATS:CELZ)
This article provides an overview of Creative Medical Technology Holdings, Inc. (CELZ) stock, including its financial actuals and estimates. It addresses frequently asked questions regarding the stock ticker, forecast, historical prices, earnings reports, revenue, net income, div
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 17:40
- Source
- TradingView
TradingView
Direct company coverage
Enterprise value to EBIT forward of Creative Medical Technology Holdings, Inc. – NASDAQ:CELZ
The article describes a financial data point for Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), specifically its Enterprise value to EBIT forward. It is presented in the context of TradingView, a platform offering various financial tools and market data.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 09:40
- Source
- TradingView
TradingView
Direct company coverage
CELZ Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Creative Medical Technology Holdings, Inc. (CELZ) stock, indicating a 1-year price forecast of $20.00 from one analyst. It also details recent stock performance, company financials, earnings estimates, market capitalization, a
- Tone
- Negative 18/100
- Event
- Analyst action
- Published
- 26 Jun 2026 07:41
- Source
- TradingView
TradingView
Direct company coverage
Number of shareholders of Creative Medical Technology Holdings, Inc. – NASDAQ:CELZ
This article focuses on Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) and provides information about the number of its shareholders. The content appears to be a stub or a section within a larger financial data platform, indicating where the shareholder data would typi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 01:12
- Source
- TradingView
Moomoo
Direct company coverage
Creative Medical Technology Holdings Files to Offer Up 3.05M Shrs and Up to 6.09M Warrants
Creative Medical Technology Holdings (CMT.A) has filed to offer up to 3.05 million shares of common stock and up to 6.09 million warrants. This move indicates potential capital raising or restructuring activities for the company. Investors will be watching for further details reg
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 23:12
- Source
- Moomoo
Stock Titan
Direct company coverage
Creative Medical (NASDAQ: CELZ) plans $5.3M stock and warrant raise
Creative Medical Technology Holdings (NASDAQ: CELZ) is planning a public offering to raise approximately $5.3 million through the sale of common stock and warrants. The company intends to use the net proceeds to fund its clinical programs, including the CELZ-201 ADAPT back pain t
- Tone
- Negative 42/100
- Event
- Market update
- Published
- 25 Jun 2026 20:12
- Source
- Stock Titan